OrganogenesisORGO
Price
$ 2.47
Market Capitalization
$ 327.46 M
Shares Outstading
132.575 M
Change
$ -0.17
Percentage Change
-6.44 %
Country
United States 🇺🇸
Industry
Drug Manufacturers—Specialty & Generic
Healthcare
Exchange
NASDAQ Capital Market
IPO
2017-01-05
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound coveri
Cash on Hand of Organogenesis ( ORGO)
Cash on Hand : $ 98.23 Million
Organogenesis has Cash on Hand of $ 98.23 Million .The current price of Organogenesis is $2.47 (-6.44 %). Cash on hand of a company,refers to the amount of physical cash and highly liquid assets that the company has immediately available to meet its short-term financial obligations and operational expenses. It includes the company's cash in bank accounts, currency, and other short-term investments that can be easily converted into cash.
Cash on Hand of Organogenesis from 2016 to 2024
Year on Year Cash on Hand of Organogenesis
| Year | Cash on Hand | Change % |
|---|---|---|
| 31-03-2023 | $ 88.69 M | -17.8% |
| 31-03-2022 | $ 107.90 M | 39.3% |
| 31-03-2021 | $ 77.46 M | 65.16% |
| 31-03-2020 | $ 46.90 M | 53.46% |
| 31-03-2019 | $ 30.56 M | 30616.73% |
| 31-03-2018 | $ 99.49 K | -79.54% |
| 31-03-2017 | $ 486.20 K | 358.41% |
| 30-06-2016 | $ 106.06 K |
Market Cap of Magnificent 7
Stock Ticker | Market Cap | Price | Change | Price(30 Days) | Country |
|---|---|---|---|---|---|
$ 3.357 T | $ 220.82 -0.70% | $ -1.56 | United States🇺🇸 | ||
$ 2.986 T | $ 401.7 -1.64% | $ -6.69 | United States🇺🇸 | ||
$ 2.522 T | $ 102.83 -4.09% | $ -4.38 | United States🇺🇸 | ||
$ 1.864 T | $ 152.13 -4.08% | $ -6.47 | United States🇺🇸 | ||
$ 1.799 T | $ 171.39 -3.65% | $ -6.5 | United States🇺🇸 | ||
$ 1.776 T | $ 7.3453 0.00% | $ 0 | Saudi Arabia🇸🇦 | ||
$ 1.266 T | $ 500.27 -3.21% | $ -16.59 | United States🇺🇸 |
